Your browser doesn't support javascript.
loading
Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.
Shindo, Tetsuya; Niinuma, Takeshi; Nishiyama, Naotaka; Shinkai, Nobuo; Kitajima, Hiroshi; Kai, Masahiro; Maruyama, Reo; Tokino, Takashi; Masumori, Naoya; Suzuki, Hiromu.
Afiliação
  • Shindo T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
  • Niinuma T; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Nishiyama N; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Shinkai N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
  • Kitajima H; Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
  • Kai M; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Maruyama R; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Tokino T; Project for Cancer Epigenome, The Cancer Institute, Japanese Foundation for Cancer, Koto-ku, Tokyo 135-8550, Japan.
  • Masumori N; Medical Genome Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Suzuki H; Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Oncotarget ; 9(36): 24457-24469, 2018 May 11.
Article em En | MEDLINE | ID: mdl-29849953

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article